Monopar Therapeutics’ (MNPR) Buy Rating Reiterated at HC Wainwright
Monopar Therapeutics (NASDAQ:MNPR – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $40.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 3.82% from the company’s current price. HC Wainwright also […]
Monopar Therapeutics (NASDAQ:MNPR – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $40.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 3.82% from the company’s current price. HC Wainwright also […]
